Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay

AIDS

Volumn 23, Issue 8, 2009, Pages 961-969

  Davies, Mary Ann ^a   Connell, Tom ^a,b,c   Johannisen, Christine ^a   Wood, Kathryn ^a   Pienaar, Sandy ^a   Wilkinson, Katalin A ^a,d   Wilkinson, Robert J ^a,d,e   Zar, Heather J ^a   Eley, Brian ^a   Beatty, David ^a   Curtis, Nigel ^b,c   NicoI, Mark P ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d National Institute for Medical Research   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Culture filtrate protein 10; Diagnosis; Early secreted antigenic target 6; Interferon; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SCHOOL CHILD; TUBERCULIN TEST; TUBERCULOSIS;

AGE FACTORS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; NUTRITIONAL STATUS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 67049171636     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832956ad     Document Type: Article

References (46)

1. Rangaka MX, Wilkinson KA, Seldon R, Van Custem G, Meintjes GA, Morroni C, et al. Effect of H1V-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175:514-520.
2. Donald PR. Childhood tuberculosis: out of control? Curr Opin Pulm Med 2002; 8:178-182.
3. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Beyers N. The burden of childhood tuberculosis and the accuracy of community-based surveillance data. Int J Tuberc Lung Dis 2006; 10:259-263.
4. Zar HJ. Childhood tuberculosis: new recognition of an old disease. Paediatr Respir Rev 2007; 8:97-98.
5. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004; 8:636-647.
6. van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, Donald PR. Childhood tuberculosis in an urban population in South Africa: burden and risk factor. Arch Dis Child 1999; 80:433-437.
7. Chintu C, Mudenda V, Lucas S, Nunn A, Lishimpi K, Maswahu D, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002; 360:985-990.
8. Jeena PM, Pillay P, Pillay T, Coovadia HM. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis 2002; 6:672-678.
9. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006; 367:926-937.
10. Hesseling AC, Cotton MF, Jennings T, Whitelaw A, Johnson LF, Eley B, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009; 48:108-114.
11. Marais BJ, Graham SM, Cotton MF, Beyers N. Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J Infect Dis 2007; 196 (Suppl 1):S76-S85.
12. Anastos K, Kalish LA, Palacio H, Benson CA, Delapenha R, Chirgwin K, et al. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1 -infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr 1999; 21:141-147.
13. Madhi SA, Gray GE, Huebner RE, Sherman G, McKinnon D, Pettifor JM. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis. Pediatr Infect Dis J 1999; 18:800-805.
14. Schaaf HS, Marais BJ, Whitelaw A, Hesseling AC, Eley B, Hussey GD, Donald PR. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis 2007; 7:140.
15. Connell TG, Rangaka MX, Curtis N, Wilkinson RJ. QuantiFER-ON-TB Gold: state of the art for the diagnosis of tuberculosis infection? Expert Rev Mol Diagn 2006; 6:663-677.
16. Lalvani A, Millington KA. T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis 2007; 20:264-271.
17. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146:340-354.
18. Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006; 61:616-620.
19. Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoS ONE 2008; 3:e2624.
20. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364:2196-2203.
21. Nicol MP, Pienaar D, Wood K, Eley B, Wilkinson RJ, Henderson H, et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis 2005; 40:1301-1308.
22. Andersen P, Munk ME, Pollack JM, Doherty MT. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356:1099-1104.
23. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 2007; 131:1898-1906.
24. Mazurek GH, Jereb J, Lobue P, lademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54:49-55.
25. Shingadia D, Novel I i V. The tuberculin skin test: a hundred, not out? Arch Dis Child 2008; 93:189-190.
26. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. Tuberculosis specific interferon gamma test. Respir Res 2006; 7:56.
27. Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, Ayles H, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002; 16:2285-2293.
28. Clark SA, Martin SL, Pozniak A, Steel A, Ward B, dunning J, et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 2007; 150:238-244.
29. Goletti D, Carrara S, Mayanja-Kizza H, Baseke J, Mugerwa M, Girardi E, Toossi Z. Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect Dis 2008; 8:11.
30. Hammond AS, McConkey SJ, Hill PC, Crozier S, Klein MR, Adegboila RA, et al. Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression. J Infect Dis 2008; 197:295-299.
31. Hoffmann M, Reichmuth M, Fantelli K, Schoch OD, Fierz W, Furrer H, Vernazza P. Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients. AIDS 2007; 21:390-392.
32. Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, Sacks H. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis 2007; 11:1190-1195.
33. Karam F, Mbow F, Fletcher H, Senghor CS, Coulibaly KD, Lefevre AM, et al. Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS ONE 2008; 3:e1441.
34. Lawn SD, Bangani N, Vogt M, Bekker LG, Badri M, Ntobong-wana M, et al. Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis 2007; 7:99.
35. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007; 175:737-742.
36. Rangaka MX, Diwakar L, Seldon R, Van Custem G, Meintjes GA, Morroni C, et al. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin Infect Dis 2007; 44:1639-1646.
37. Nakaoka H, Lawson L, Bertel Squire S, Coulter B, Ravn P, Brock I, et al. Risk for tuberculosis among children. Emerg Infect Dis 2006; 12:1383-1388.
38. Spyridis N, Chakraborty R, Sharland M, Heath PT. Early diagnosis of tuberculosis using an INF-gamma assay in a child with HI V-1 infection and a very low CD4 count. Scand J Infect Dis 2007; 39:919-921.
39. Gooding S, Chowdhury O, Hinks T, Richeldi L, Losi M, Ewer K, et al. Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice. J Infect 2007; 54:e169-e174.
40. Higuchi K, Harada N, Fukazawa K, Mori T. Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis. Tuberculosis (Edinb) 2008; 88:244-248.
41. Janssens JP, Roux-Lombard P, Perneger T, Metzger M, Vivien R, Rochat T. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis. Eur Respir J 2007; 30:722-728.
42. Mantegani P, Piana F, Codecasa L, Galli L, Scarpellini P, Lazzarin A, et al. Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection. Clin Med Res 2006; 4:266-272.
43. Ewer K, Deeks J, Alvarez L, Bryant G, WallerS, Andersen P, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361:1168-1173.
44. Fox A, Jeffries DJ, Hill PC, et al. ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease. Trans R Soc Trop Med Hyg 2007; 101:691-698.
45. Hill PC, Brookes RH, Adetifa IMO, Fox A, Jackson-Sillah D, Lugos MD, et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Myocbacterium tuberculosis. Pediatrics 2006; 117:1542-1548.
46. Richeldi L, Ewer K, Losi M, Bergamini BM, Millington K, Fabbri LM, Lalvani A. T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics 2007; 119:e1-e5.